Glipizide

Product NDC
16729-139
11-digit product format
167290139
Labeler code
16729
Product ID
16729-139_ecb57512-ac6b-ad23-e053-2a95a90aacb7
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
glipizide
Dosage form
TABLET
Route
ORAL
Labeler
Accord Healthcare Inc.
Application
ANDA074550
Marketing category
ANDA
Marketing start
2011-07-18
Marketing end
0000-00-00
Substance
GLIPIZIDE
Active strength
5 mg/1
Pharmacologic classes
Sulfonylurea Compounds [CS], Sulfonylurea [EPC]
NDC exclude flag
No
Listing certified through
2023-12-31
Current FDA listing
Historical FDA.report record

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
ec4adfb0-aabc-95b9-ad07-5cb8f8533a09Product name220250625
b1de1ca9-d9db-4f4b-2103-09e2014d30d5Product name520180912
2dee091b-3b8c-d27a-b1ba-fcb0d32e776aProduct name120140508

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
16729-139-00EA - Each16729-1392d08b617-2efe-4b52-9970-28e9b63381ef12012-07-24
16729-139-16EA - Each16729-139ae8cded9-3ddd-4b92-9402-24f0361db35c12012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
glipizideACTIVE INGREDIENTX7WDT95N5CGLIPIZIDE TABLET [TYA PHARMACEUTICALS]2
glipizideACTIVE MOIETYX7WDT95N5CGLIPIZIDE TABLET [TYA PHARMACEUTICALS]2
ANHYDROUS LACTOSEINACTIVE INGREDIENT3SY5LH9PMKGLIPIZIDE TABLET [TYA PHARMACEUTICALS]2
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61UGLIPIZIDE TABLET [TYA PHARMACEUTICALS]2
SILICON DIOXIDEINACTIVE INGREDIENTETJ7Z6XBU4GLIPIZIDE TABLET [TYA PHARMACEUTICALS]2
STARCH, CORNINACTIVE INGREDIENTO8232NY3SJGLIPIZIDE TABLET [TYA PHARMACEUTICALS]2
STEARIC ACIDINACTIVE INGREDIENT4ELV7Z65APGLIPIZIDE TABLET [TYA PHARMACEUTICALS]2
GLIPIZIDEACTIVE INGREDIENTX7WDT95N5CGLIPIZIDE TABLET [STATE OF FLORIDA DOH CENTRAL PHARMACY]1
glipizideACTIVE MOIETYX7WDT95N5CGLIPIZIDE TABLET [STATE OF FLORIDA DOH CENTRAL PHARMACY]1
ANHYDROUS LACTOSEINACTIVE INGREDIENT3SY5LH9PMKGLIPIZIDE TABLET [STATE OF FLORIDA DOH CENTRAL PHARMACY]1
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61UGLIPIZIDE TABLET [STATE OF FLORIDA DOH CENTRAL PHARMACY]1
SILICON DIOXIDEINACTIVE INGREDIENTETJ7Z6XBU4GLIPIZIDE TABLET [STATE OF FLORIDA DOH CENTRAL PHARMACY]1
STARCH, CORNINACTIVE INGREDIENTO8232NY3SJGLIPIZIDE TABLET [STATE OF FLORIDA DOH CENTRAL PHARMACY]1
STEARIC ACIDINACTIVE INGREDIENT4ELV7Z65APGLIPIZIDE TABLET [STATE OF FLORIDA DOH CENTRAL PHARMACY]1

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
310488glipiZIDE 10 MG Oral TabletPSNa98b2568-0ce3-4c80-a1aa-a0bf5884564a7
310490glipiZIDE 5 MG Oral TabletPSNa98b2568-0ce3-4c80-a1aa-a0bf5884564a7
310488glipizide 10 MG Oral TabletSCDa98b2568-0ce3-4c80-a1aa-a0bf5884564a7
310490glipizide 5 MG Oral TabletSCDa98b2568-0ce3-4c80-a1aa-a0bf5884564a7
310490glipiZIDE 5 MG Oral TabletPSN494ce357-e390-65e8-e054-00144ff88e882
310490glipiZIDE 5 MG Oral TabletPSNdeb9ba3d-0141-4701-bd59-0fad505e02202
310490glipizide 5 MG Oral TabletSCD494ce357-e390-65e8-e054-00144ff88e882
310490glipizide 5 MG Oral TabletSCDdeb9ba3d-0141-4701-bd59-0fad505e02202
310490glipiZIDE 5 MG Oral TabletPSN463a6f4a-c833-2e89-e054-00144ff8d46c1
310490glipiZIDE 5 MG Oral TabletPSNb545266d-9d05-4d7d-993f-df36592751e41
310490glipiZIDE 5 MG Oral TabletPSNc1694f5d-c7ac-4d6e-a9e1-75e0cd82e0fa1
310490glipizide 5 MG Oral TabletSCD463a6f4a-c833-2e89-e054-00144ff8d46c1
310490glipizide 5 MG Oral TabletSCDb545266d-9d05-4d7d-993f-df36592751e41
310490glipizide 5 MG Oral TabletSCDc1694f5d-c7ac-4d6e-a9e1-75e0cd82e0fa1

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
16729-139-0016729013900100 TABLET in 1 BOTTLE (16729-139-00) 100 tablet2011-07-180000-00-00NoNoCurrent
16729-139-1616729013916500 TABLET in 1 BOTTLE (16729-139-16) 500 tablet2011-07-180000-00-00NoNoCurrent